GE HealthCare Technologies Inc. Common Stock (GEHC) Financial Statements
Historical financial data — 13 statements covering FY2023–FY2025
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), adv...
GE HealthCare Technologies Inc. Common Stock's revenue increased 4.8% year over year, from $19.67B to $20.63B.
Net income increased 4.6% over the same period, from $1.99B to $2.08B.
Total debt increased by 11.8% to $10.00B.
The debt-to-equity ratio stands at 0.96, indicating a moderate leverage profile.
Operating cash flow grew 1.6% to $1.99B.
GE HealthCare Technologies Inc. Common Stock maintains a healthy net profit margin of 10.1%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2023 | $14.35B+50.6% | $1.17B | $5.77B | $1.75B | $1.05B | $32.38B | $10.26B | $7.13B |
| Q1 FY2024 | $4.65B-67.6% | $374.0M | $1.90B | $540.0M | $419.0M | $32.21B | $9.26B | $7.41B |
| Q2 FY2024 | $9.49B+104.1% | $802.0M | $3.90B | $1.15B | $300.0M | $31.85B | $9.24B | $7.80B |
| Q3 FY2024 | $14.35B+51.3% | $1.27B | $5.93B | $1.82B | $1.04B | $33.85B | $10.31B | $8.32B |
| Q1 FY2025 | $4.78B-66.7% | $564.0M | $2.01B | $629.0M | $250.0M | $33.59B | $8.76B | $9.19B |
| Q2 FY2025 | $9.78B+104.8% | $1.05B | $4.00B | $1.28B | $344.0M | $35.50B | $10.28B | $9.71B |
| Q3 FY2025 | $14.93B+52.6% | $1.50B | $5.99B | $1.94B | $937.0M | $36.13B | $10.28B | $9.99B |
| Q1 FY2026 | $5.13B-65.6% | $389.0M | $1.98B | $515.0M | $290.0M | $37.13B | $10.13B | $10.67B |
Balance Sheet Summary (Latest Period)
Total Assets
$36.91B
Total Liabilities
$26.31B
Total Equity
$10.38B
Cash & Equivalents
N/A
Total Debt
$10.00B
Current Assets
$12.50B
Current Liabilities
$9.11B
Retained Earnings
$5.28B